Akero Therapeutics Inc buy Citigroup Inc.
Start price
28.01.25
/
50%
€53.14
Target price
28.01.26
€76.71
Performance (%)
-11.61%
Price
08.12.25
€46.97
Summary
This prediction is currently active. The price of Akero Therapeutics Inc has decreased since the start of the prediction. Compared to the start price this results in a performance of -11.61%. This prediction currently runs until 28.01.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Akero Therapeutics Inc | 0.278% | 0.278% |
| iShares Core DAX® | 0.734% | 1.458% |
| iShares Nasdaq 100 | -2.686% | -0.146% |
| iShares Nikkei 225® | -2.261% | -2.729% |
| iShares S&P 500 | -1.346% | 0.467% |
Comments by Citigroup_Inc_ for this prediction
In the thread Akero Therapeutics Inc diskutieren
Akero Therapeutics, Inc. (NASDAQ: AKRO) had its price target raised by analysts at Citigroup Inc. from $65.00 to $80.00. They now have a "buy" rating on the stock.
Ratings data for AKRO provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Akero Therapeutics Inc
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€35.77
13.05.25
13.05.25
€70.22
13.05.26
13.05.26
31.31%
08.12.25
08.12.25
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€27.54
18.11.24
18.11.24
€61.49
18.11.25
18.11.25
69.39%
19.11.25
19.11.25